Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (601-610 of 853) with videos related to

Pageof 86
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaR C Stuart-Harris, P G Harper, C A Parsons, et al.
Journal of Oral Pathology|August 1, 1984
The oral carriage of yeasts and coliforms in patients on cytotoxic therapyL P Samaranayake, K C Calman, M M Ferguson, et al.
Cancer Journal (Sudbury, Mass.)|October 15, 2009
Biomarker-driven early clinical trials in oncology: a paradigm shift in drug developmentDaniel S W Tan, George V Thomas, Michelle D Garrett, et al.
Radiology|August 11, 2011
Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficientsStavroula Kyriazi, David J Collins, Christina Messiou, et al.
The British Journal of Ophthalmology|November 15, 2015
The impact of donor age and endothelial cell density on graft survival following penetrating keratoplastyM J Wakefield, W J Armitage, M N A Jones, et al.
Retina (Philadelphia, Pa.)|October 22, 2024
OPTICAL COHERENCE TOMOGRAPHY FEATURES ASSOCIATED WITH VITREOMACULAR TRACTION RELEASE AND MACULAR HOLE SIZE PROGRESSION FOLLOWING TREATMENT WITH OCRIPLASMINNavid Johannigmann-Malek, Danilo Iannetta, Yalin Zheng, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Eye (London, England)|March 16, 2022
Thinning rate over 24 months in ultrathin DSAEKMatthew T Fenech, Giulia Coco, Luca Pagano, et al.
British Journal of Cancer|November 1, 1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistJ Cassidy, V Raina, C Lewis, et al.
Journal of Clinical Microbiology|July 5, 2003
Simplifying collection of corneal specimens in cases of suspected bacterial keratitisStephen B Kaye, Prasad G Rao, Godfrey Smith, et al.
Pageof 86

Showing results (601-610 of 853) with videos related to

Sort By:
Pageof 86
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaR C Stuart-Harris, P G Harper, C A Parsons, et al.
Journal of Oral Pathology|August 1, 1984
The oral carriage of yeasts and coliforms in patients on cytotoxic therapyL P Samaranayake, K C Calman, M M Ferguson, et al.
Cancer Journal (Sudbury, Mass.)|October 15, 2009
Biomarker-driven early clinical trials in oncology: a paradigm shift in drug developmentDaniel S W Tan, George V Thomas, Michelle D Garrett, et al.
Radiology|August 11, 2011
Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficientsStavroula Kyriazi, David J Collins, Christina Messiou, et al.
The British Journal of Ophthalmology|November 15, 2015
The impact of donor age and endothelial cell density on graft survival following penetrating keratoplastyM J Wakefield, W J Armitage, M N A Jones, et al.
Retina (Philadelphia, Pa.)|October 22, 2024
OPTICAL COHERENCE TOMOGRAPHY FEATURES ASSOCIATED WITH VITREOMACULAR TRACTION RELEASE AND MACULAR HOLE SIZE PROGRESSION FOLLOWING TREATMENT WITH OCRIPLASMINNavid Johannigmann-Malek, Danilo Iannetta, Yalin Zheng, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Eye (London, England)|March 16, 2022
Thinning rate over 24 months in ultrathin DSAEKMatthew T Fenech, Giulia Coco, Luca Pagano, et al.
British Journal of Cancer|November 1, 1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistJ Cassidy, V Raina, C Lewis, et al.
Journal of Clinical Microbiology|July 5, 2003
Simplifying collection of corneal specimens in cases of suspected bacterial keratitisStephen B Kaye, Prasad G Rao, Godfrey Smith, et al.
Pageof 86